SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

AMC Robotics Corp. engages in developing and deploying AI-enabled robotics and smart security solutions, especially for warehouse automation, enterprise security, robotics patrol/incident-response and logistics automation. The company is headquartered in New York, NY.

AMC Robotics Corp.

AMCI is trending with community members actively discussing its potential for a short squeeze and comparing it to other low-float runners like SMX. The stock's high volatility and recent price action are fueling speculation, with some traders eyeing potential targets while others remain cautious. Discussions also include potential sympathy plays and sector catalysts for robotics.

Tilray Brands, Inc. engages as a consumer packaged goods company, which focuses on medical cannabis research and the cultivation, processing, and distribution of cannabis products worldwide. It operates through the followings segments: Cannabis, Distribution, Beverage, and Wellness. The Cannabis segment focuses on cultivation, production, distribution, and sale of both medical and adult-use cannabis products. The Distribution segment is involved in purchase, resale, and distribution of pharmaceutical and wellness products. The Beverage segment refers to the production, marketing, and sale of beverages. The Wellness segment represents the production, marketing, and distribution of hemp-based food and other wellness products. The company was founded on January 24, 2018 and is headquartered in Leamington, Canada.

Tilray Brands Inc

TLRY is trending amid speculation and conflicting reports surrounding potential cannabis rescheduling by the Trump administration. Community discussions revolve around whether an executive order will be signed, with some anticipating a positive announcement and others expressing skepticism based on past disappointments. The stock's volatility and potential for a short squeeze are also hot topics.

Advisorshares Trust - AdvisorShares Pure US Cannabis ETF

AdvisorShares Pure US Cannabis ETF

MSOS is trending amid speculation that the Trump administration may soon reclassify marijuana, potentially as early as Monday, sparking excitement within the cannabis sector. The community is actively discussing the implications of this potential policy change on US-based cannabis companies and debating whether this time the long-awaited catalyst will finally materialize. Some traders are wary of previous false alarms, while others are eagerly anticipating a substantial re-rating of cannabis stocks.

Applied Digital Corp. is a technology company, which engages in the provision of development and operation of data centers which provide computing power. It operates through the Data Center Hosting Business and HPC Hosting Business segments. The Data Center Hosting Business segment provides energized infrastructure services to crypto mining customers. The HPC Hosting Business segment focuses on the designing, constructing, and operating data centers tailored to support high power density applications like HPC and AI. The company was founded by Wesley Carl Cummins and Jason Zhang in May 2001 and is headquartered in Dallas, TX.

Applied Digital Corporation

APLD is trending downwards as investors discuss a recent sharp decline, speculating about potential manipulation and stop-loss raids. Community members are weighing the impact of broader AI sector sentiment and awaiting news catalysts, such as hyperscaler deals or company statements. Some traders are taking advantage of the dip, while others express concern about the stock's short-term prospects, linking it to debt and AI spending.

Tesla, Inc. engages in the design, development, manufacture, and sale of electric vehicles and energy generation and storage systems. It operates through the Automotive and Energy Generation and Storage segments. The Automotive segment includes the design, development, manufacture, sale, and lease of electric vehicles as well as sales of automotive regulatory credits. The Energy Generation and Storage segment is involved in the design, manufacture, installation, sale, and lease of solar energy generation, energy storage products, and related services and sales of solar energy systems incentives. The company was founded by Jeffrey B. Straubel, Elon Reeve Musk, Martin Eberhard, and Marc Tarpenning on July 1, 2003 and is headquartered in Austin, TX.

Tesla Inc

Tesla's stock is trending upwards amid discussions about its autonomous driving capabilities and robotaxi program, with some highlighting bullish technical indicators and potential for further gains. Community chatter revolves around the stock's high valuation, the impact of call options, and speculation on future price movements. Some investors express concerns about fundamentals, while others remain optimistic about long-term growth.

Radiopharm Theranostics Ltd. operates as a pre-clinical and clinical research company. It focuses on the development of radiopharmaceutical products for diagnostic and therapeutic uses in areas of high unmet medical need. The company is founded by Paul A. Hopper in 2021 headquartered Carlton, Australia.

Radiopharm Theranostics Ltd - ADR

RADX is trending due to positive interim results from its RAD 101 Phase 2b imaging trial, showing promise in brain metastases diagnosis, with a webinar scheduled for further discussion. The community is actively discussing the potential for a short squeeze and significant price movement based on this news and the company's upcoming webinar. Some traders are pointing to the company's cash runway and potential for acquisition, while others express concern about potential dilutions and recent trading volatility.

Artiva Biotherapeutics, Inc. operates as a biotechnology company for the treatment of hematologic cancers. It offers NK cell therapies for cancer. The company was founded by Thomas J. Farrell in 2019 and is headquartered in San Diego, CA.

Artiva Biotherapeutics Inc

Artiva Biotherapeutics is trending due to positive early trial results for its AlloNK cell therapy in autoimmune diseases, which earned it an FDA Fast Track designation; the community is actively discussing potential price targets and whether to hold the stock, especially given Wedbush's increased price target. Chatter surrounds the significance of the news, as well as whether this surge has more room to run.

Ford Motor Co. engages in the manufacture, distribution, and sale of automobiles. It operates through the following segments: Ford Blue, Ford Model E, Ford Pro, Ford Next, Ford Credit, and Corporate Other. The Ford Blue, Ford Model E, and Ford Pro segment includes the sale of Ford and Lincoln vehicles, service parts, and accessories, together with the associated costs to develop, manufacture, distribute, and service the vehicles, parts, and accessories. The Ford Next segment is involved in the expenses and investments for emerging business initiatives aimed at creating value for Ford in vehicle-adjacent market segments. The Ford Credit segment consists of the Ford Credit business on a consolidated basis, which is primarily vehicle-related financing and leasing activities. The Corporate Other segment refers to corporate governance expenses, past service pension and OPEB income and expense, interest income and gains and losses from cash, cash equivalents, and marketable securities, and foreign exchange derivatives gains, and losses associated with intercompany lending. The company was founded by Henry Ford on June 16, 1903 and is headquartered in Dearborn, MI.

Ford Motor Co.

Ford Motor Co

Ford is trending as investors digest a ~$19.5 billion charge tied to EV write-downs and a shift towards hybrid vehicles, with some halting EV F-150 plans. The community debates whether this is a positive pivot for affordability and profitability, or a sign of government influence and EV market struggles. Discussions also mention Ford's valuation compared to competitors like Tesla, and broader sector trends related to tariffs and EV adoption.

Immunome, Inc. is a biopharmaceutical company, which engages in the discovery and development of antibody therapeutics products. It also focuses on oncology and infectious disease areas. The company was founded by Scott K. Dessain and Gregory P. Licholai on March 2, 2006 and is headquartered in Bothell, WA.

Immunome Inc

IMNM is trending due to positive Phase 3 trial results for its desmoid tumor drug, Varegacestat, with community members discussing its potential FDA approval in 2026. However, the company's announcement of a proposed public offering of common stock is causing some disappointment and volatility. Some traders are speculating on a potential retail war against hedge funds and a possible buyout candidate.

Kyverna Therapeutics, Inc. is a cell therapy clinical-stage biotechnology company, which engages in the provision of treatments and potential cures for serious autoimmune diseases. The company was founded in June 2018 and is headquartered in Emeryville, CA.

Kyverna Therapeutics Inc.

Kyverna Therapeutics is trending due to community discussion around a recent offering, with some investors viewing it as a strategic move by someone wanting a large stake. Others express concern about dilution, while some highlight positive Phase 2 data and analyst upgrades, particularly from Morgan Stanley, who raised their price target; Many are looking to MG data and potential buyout catalysts in the coming year.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


ORPOF
OSE Immunotherapeutics

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest ORPOF News

ORPOFOSE Immunotherapeutics